Merck Pushes Discount Zocor; Health Plans Are Wary, But Pfizer Is Concerned
Executive Summary
The mixed response to Merck's efforts to reach rebate agreements with health plans to place brand Zocor on the lowest cost-sharing tiers of their formularies suggests it is unlikely such a strategy would be broadly adopted by brand firms going forward
You may also be interested in...
Crestor Discounting Keeps Allergan's Generic Off UnitedHealth Formulary
UnitedHealth will drop AstraZeneca's brand from coverage after competition drives down price of generic rosuvastatin.
Lifecycle Management Trends In China Show The Need To Get Ready For Fewer, Better Generics
In China, multinational pharmaceutical companies are not so worried about the patent cliff, as many off-patent products enjoy premium pricing and high-growth rates even when dozens of generics exist. But how long will the party last?
Can Watson Give Birth To A Pregnancy Franchise As It Helps Lay Lipitor To Rest?
Watson is progressing on a multi-year effort to diversify beyond its core U.S. generics business into branded drugs and international markets.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: